SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya

BACKGROUND: In sub-Saharan Africa many people who inject drugs (PWID) are living with undiagnosed or untreated HIV and experience high levels of poverty and conditions that can contribute to worse outcomes from SARS-CoV-2 infection. Identifying the burden of SARS-CoV-2 infection in marginalized popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Doshi, Shradha, Kingston, Hanley, Tseng, Ashley S., Chohan, Bhavna H., Sambai, Betsy, Guthrie, Brandon L., Monroe-Wise, Aliza, Mbogo, Loice W., Masyuko, Sarah, Tram, Khai Hoan, Sinkele, William, Macharia, Paul, Bukusi, David, Herbeck, Joshua T., Farquhar, Carey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947430/
https://www.ncbi.nlm.nih.gov/pubmed/36823596
http://dx.doi.org/10.1186/s12954-023-00754-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947430/
https://www.ncbi.nlm.nih.gov/pubmed/36823596
http://dx.doi.org/10.1186/s12954-023-00754-5

Ejemplares similares